Cargando…

Silencing RIF1 decreases cell growth, migration and increases cisplatin sensitivity of human cervical cancer cells

Replication timing regulatory factor 1 (RIF1) plays an important role in DNA replication regulation, stem cell pluripotency and DNA repair pathway. However, little is known about the molecular mechanisms and physiological significance of RIF1 in cancer and chemotherapy efficacy. In this study, we fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mei, Ying, Peng, Chen, Liu, Yong-Bin, Wang, Jing, Zhou, Hong-Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739795/ https://www.ncbi.nlm.nih.gov/pubmed/29291010 http://dx.doi.org/10.18632/oncotarget.22315

Ejemplares similares

Methylation-Mediated Silencing of MicroRNA-211 Decreases the Sensitivity of Melanoma Cells to Cisplatin
por: Li, Ning, et al.
Publicado: (2019)

Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin
por: Qu, Yang, et al.
Publicado: (2022)

Curcumin increases breast cancer cell sensitivity to cisplatin by decreasing FEN1 expression
por: Zou, Jiao, et al.
Publicado: (2018)

PDCD5 transfection increases cisplatin sensitivity and decreases invasion in hepatic cancer cells
por: FAN, GUI-LING, et al.
Publicado: (2015)

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
por: Liang, Sixian, et al.
Publicado: (2014)

DAB2IP decreases cell growth and migration and increases sensitivity to chemotherapeutic drugs in colorectal cancer
por: Wu, Guanting, et al.
Publicado: (2021)

Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin
por: Li, Weijia, et al.
Publicado: (2023)

Effect of cyclin-dependent kinase 7 silencing on cisplatin sensitivity in endometrial carcinoma cells
por: LIU, WEN-XIN, et al.
Publicado: (2015)

Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
por: Liang, Sixian, et al.
Publicado: (2022)

MicroRNA-22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells
por: Zhou, Xiang, et al.
Publicado: (2018)

Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells
por: Zhang, Xiaopeng, et al.
Publicado: (2016)

MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer
por: Li, Jiarui, et al.
Publicado: (2012)

Silencing of Barkor/ATG14 sensitizes osteosarcoma cells to cisplatin-induced apoptosis
por: ZHAO, ZHIFANG, et al.
Publicado: (2014)

Elevated extracellular calcium ions accelerate the proliferation and migration of HepG2 cells and decrease cisplatin sensitivity
por: Xu, Haozhe, et al.
Publicado: (2023)

NRBP2 Overexpression Inhibits Cell Proliferation and Migration and Increases Cisplatin Sensitivity in Intrahepatic Cholangiocarcinoma
por: Li, Xiaopeng, et al.
Publicado: (2017)

Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescence
por: Hernandez-Flores, Georgina, et al.
Publicado: (2011)

Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin
por: Campagna, Roberto, et al.
Publicado: (2020)

Silencing of phosphoglucose isomerase/autocrine motility factor decreases U87 human glioblastoma cell migration
por: LI, YANG, et al.
Publicado: (2016)

Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer
por: Nam, Ah-Rong, et al.
Publicado: (2019)

Exosomes: Decreased Sensitivity of Lung Cancer A549 Cells to Cisplatin
por: Xiao, Xia, et al.
Publicado: (2014)

CD133 antisense suppresses cancer cell growth and increases sensitivity to cisplatin in vitro
por: BLANCAS-MOSQUEDA, MARISOL, et al.
Publicado: (2012)

FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells
por: Huang, Ming-ju, et al.
Publicado: (2018)

RIF1 promotes tumor growth and cancer stem cell-like traits in NSCLC by protein phosphatase 1-mediated activation of Wnt/β-catenin signaling
por: Mei, Ying, et al.
Publicado: (2018)

NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells
por: Tao, Tao, et al.
Publicado: (2017)

Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin
por: Xie, Si Ming, et al.
Publicado: (2008)

RNA silencing of integrin-linked kinase increases the sensitivity of the A549 lung cancer cell line to cisplatin and promotes its apoptosis
por: ZHAO, XIAOZHEN, et al.
Publicado: (2015)

Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
por: Bieg, Dominik, et al.
Publicado: (2018)

Nanoparticle-Mediated Gene Silencing for Sensitization of Lung Cancer to Cisplatin Therapy
por: Feldmann, Daniel P., et al.
Publicado: (2020)

Correction: RIF1 promotes tumor growth and cancer stem cell-like traits in NSCLC by protein phosphatase 1-mediated activation of Wnt/β-catenin signaling
por: Mei, Ying, et al.
Publicado: (2021)

Silencing of Twist1 sensitizes NSCLC cells to cisplatin via AMPK-activated mTOR inhibition
por: Jin, H-O, et al.
Publicado: (2012)

Silencing of TGIF sensitizes MDA-MB-231 human breast cancer cells to cisplatin-induced apoptosis
por: Pan, Teng, et al.
Publicado: (2018)

Gene silencing of NOB1 by lentivirus suppresses growth and migration of human osteosarcoma cells
por: CHEN, BINGPENG, et al.
Publicado: (2014)

Gene silencing of NOB1 by lentivirus suppresses growth and migration of human osteosarcoma cells
por: Chen, Bingpeng, et al.
Publicado: (2022)

Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells
por: Rabelo-Fernández, Robert J., et al.
Publicado: (2022)

Bag-1 Silence Sensitizes Non-Small Cell Lung Cancer Cells To Cisplatin Through Multiple Gene Pathways
por: Lv, Jiling, et al.
Publicado: (2019)

Leonurine Promotes Cisplatin Sensitivity in Human Cervical Cancer Cells Through Increasing Apoptosis and Inhibiting Drug-Resistant Proteins
por: Lin, Min, et al.
Publicado: (2020)

RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression
por: Liu, Yong-Bin, et al.
Publicado: (2018)

Vasohibin 2 Decreases the Cisplatin Sensitivity of Hepatocarcinoma Cell Line by Downregulating p53
por: Li, Zhanjun, et al.
Publicado: (2014)

The ATR inhibitor VE-821 increases the sensitivity of gastric cancer cells to cisplatin
por: Su, Haochen, et al.
Publicado: (2023)

Effect of RIF1 on response of non-small-cell lung cancer patients to platinum-based chemotherapy by regulating MYC signaling pathway
por: Mei, Ying, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oe7kci9g63c3rua1kjn5a5p504